These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4062999)

  • 21. Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome.
    Bhattacharya SM; Jha A
    Fertil Steril; 2012 Oct; 98(4):1053-9. PubMed ID: 22795636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyproterone acetate in the treatment of metastatic cancer of the male breast.
    Lopez M
    Cancer; 1985 May; 55(10):2334-6. PubMed ID: 3986737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cyproterone acetate therapy on gonadotropin response to synthetic luteinizing hormone-releasing hormone (LRH) in girls with idiopathic precocious puberty.
    Angeli A; Boccuzzi G; Bisbocci D; Fonzo D; Frajria R; DeSanctis C; Ceresa F
    J Clin Endocrinol Metab; 1976 Mar; 42(3):551-60. PubMed ID: 767354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a cyproterone-containing oral contraceptive on hormonal levels in polycystic ovarian disease.
    Calaf-Alsina J; Rodriguez-Espinosa J; Cabero-Roura A; Lenti-Paoli O; Mora-Brugues J; Esteban-Altirriba J
    Obstet Gynecol; 1987 Feb; 69(2):255-8. PubMed ID: 2949170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-term treatment of virilized women with cyproterone acetate (author's transl)].
    Abrahamsson L; Hackl H; Lindström B; Sogn J
    Wien Klin Wochenschr; 1981 Sep; 93(17):552-6. PubMed ID: 6458162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl oestradiol/cyproterone acetate.
    Armstrong VL; Wiggam MI; Ennis CN; Sheridan B; Traub AI; Atkinson AB; Bell PM
    QJM; 2001 Jan; 94(1):31-7. PubMed ID: 11161134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex hormone modulation in systemic lupus erythematosus: still a therapeutic option?
    Asherson RA; Lahita RG
    Ann Rheum Dis; 1991 Dec; 50(12):897-8. PubMed ID: 1768154
    [No Abstract]   [Full Text] [Related]  

  • 28. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
    Falsetti L; Dordoni D; Gastaldi C; Gastaldi A
    Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Corticosteroids and Cyclophosphamide on Sex Hormone Profiles in Male Patients With Systemic Lupus Erythematosus or Systemic Sclerosis.
    Arnaud L; Nordin A; Lundholm H; Svenungsson E; Hellbacher E; Wikner J; Zickert A; Gunnarsson I
    Arthritis Rheumatol; 2017 Jun; 69(6):1272-1279. PubMed ID: 28141919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired pregnenolone secretion after combined cyproterone acetate and ethynyl estradiol therapy in hirsute patients.
    Inaudi P; D'Ambrogio G; Massafra C; Facchini V; Genazzani AR
    Gynecol Obstet Invest; 1982; 14(2):106-20. PubMed ID: 6288518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cyproterone acetate. 15 cases of hirsutism treated for 1 year].
    Houdent C; Kuhn JM; Balacheff O; Leclerc P; Legrand A; Wolf LM
    Ann Endocrinol (Paris); 1983; 44(6):397-401. PubMed ID: 6234850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of oestrogen or cyproterone acetate treatment on adrenocortical function in prostate carcinoma patients.
    Schürmeyer T; Graff J; Senge T; Nieschlag E
    Acta Endocrinol (Copenh); 1986 Mar; 111(3):360-7. PubMed ID: 2421511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of cyproterone acetate on pituitary-ovarian function and clinical symptoms in hirsute women.
    Lunell NO; Zador G; Carlström K; Eneroth P; Patek E; Wager J
    Acta Endocrinol (Copenh); 1982 May; 100(1):91-7. PubMed ID: 6214134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of antiandrogenic treatment with cyproterone acetate on the sexual tonus in virilized women].
    Abrahamsson L; Hackl H; Lindström B
    Wien Klin Wochenschr; 1983 Jan; 95(2):49-52. PubMed ID: 6222545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormalities of sex hormones in men with systemic lupus erythematosus.
    Carrabba M; Giovine C; Chevallard M; Angelini M; Ambrosi B; Travaglini P
    Clin Rheumatol; 1985 Dec; 4(4):420-5. PubMed ID: 3830519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocrine effects of cyproterone acetate in patients with prostatic cancer.
    Isurugi K; Fukutani K; Ishida H; Hosoi Y
    J Urol; 1980 Feb; 123(2):180-3. PubMed ID: 7354512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effects of cyproterone acetate or a long-acting gonadotropin-releasing hormone agonist in polycystic ovarian disease.
    Couzinet B; Le Strat N; Brailly S; Schaison G
    J Clin Endocrinol Metab; 1986 Oct; 63(4):1031-5. PubMed ID: 2943752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism.
    Sahin Y; Bayram F; Keleştimur F; Müderris I
    J Endocrinol Invest; 1998 Jun; 21(6):348-52. PubMed ID: 9699125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of hirsutism by the long-term administration of the anti-androgen cyproterone acetate].
    Stárka L; Hampl R
    Cas Lek Cesk; 1988 Jun; 127(25):790-3. PubMed ID: 2970298
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical and hormonal aspects of systemic lupus erythematosus in men].
    Alekberova ZS; Folomeev MIu
    Ter Arkh; 1983; 55(7):85-7. PubMed ID: 6623393
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.